![](/img/cover-not-exists.png)
Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes
Wilding, John PH, Gause-Nilsson, Ingrid, Persson, AndersYear:
2007
Language:
english
Journal:
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease
DOI:
10.3132/dvdr.2007.040
File:
PDF, 114 KB
english, 2007